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Peripheral blood and tissue eosinophilia characterize 
trichinellosis in humans, and present in addition to the 
increased total IgE levels that occur in many helminth 
infections. Both processes are the consequence of 
T-helper 2 activation. Blood and tissue eosinophilia 
begins with eosinophilopoiesis in the bone marrow, 
which is followed by the migration of eosinophils through 
the circulatory system, the eosinophil infiltration of 
tissues at the inflammatory foci and, finally, 
degranulation and cell death. Recently, some aspects of 
eosinophilia caused by Trichinella spiralis infection have 
been elucidated; however, the protective role of this 
population of cells against Trichinella parasites remains 
controversial. Furthermore, when eosinophils are 
numerous, they can be toxic for host tissues. This review 
discusses these issues in both human and rodent 
infection models. 
Eosinophilopoiesis 
Trichinellosis is a worldwide zoonosis, and there are an 
estimated ten million people at risk for this parasitic 
infection [1]. The life cycle of Trichinella parasites consists 
of the enteral phase, which lasts 3–4 weeks in humans, and 
the parenteral phase, which starts after the arrival of 
migrant larvae in the striated skeletal muscle fibers. At the 
beginning of the parenteral phase, an increase in blood and 
tissue eosinophil levels is observed [2].  
Trichinella antigens stimulate T cells to produce 
cytokines that induce eosinophilopoiesis in the infected 
host [3,4] (Figure 1). When spleen lymphocytes that were 
obtained from mice 4–6 weeks after infection with 
Trichinella spiralis were cultured with somatic antigens [5] 
or excretory and/or secretory products from muscle larvae 
(ML) [6], the conditioned medium induced eosinophil 
production from normal, nonadherent syngeneic 
bone-marrow cells. Eosinophilic responses in 
Trichinella-infected mice were dependent on the release of 
soluble products from lymphocytes that were sensitized to 
the parasite antigen, whereas the addition of the antigen to 
either non-sensitized lymphocytes or lymphocytes 
sensitized by the Calmette-Guérin bacillus did not induce 
colony-stimulating activity [5]. However, a direct injection 
of the antigen failed to induce eosinophilia in rats [7]. 
Interleukin-5 (IL-5) is an important cytokine that is 
involved in eosinophilopoiesis in mice that are infected 
with T. spiralis [8] (Table 1). Immunization with ML 
antigens combined with adjuvant induces a type-2-biased 
cytokine response and generates a high level of IL-5 [9–11]. 
Wang et al. [12] suggested that the interactions between 
antigen-presenting cells and CD4+ T cells through 
co-stimulatory CD86 are crucial to IL-5 production in T. 
spiralis infections. The intraperitoneal injection of 
Trichinella-infected BALB/c mice with anti-CD80 and/or 
anti-CD86 monoclonal antibody (moAb) suppressed 
eosinophilia. The combination of both moAbs also 
effectively reduced the in vitro production of IL-5 in 
mesenteric lymph node cells that were stimulated with 
somatic antigen; however, when further studied, the 
in vitro production of IL-5 was only reduced in the presence 
of anti-CD86 where anti-CD80 alone was ineffective. When 
co-stimulatory factor interactions between intercellular 
adhesion molecule-1 and lymphocyte function antigen-1, or 
vascular cell adhesion molecule (VCAM) and very late 
antigen-4 were blocked in vitro, the production of IL-5 was 
not suppressed as effectively as it was in anti-CD86 moAb 
treatment. 
Eosinophil migration and infiltration to tissues 
Although homogenates of T. spiralis ML attract eosinophils 
[13], the migration of eosinophils into tissues is also the 
result of the action of chemokines, in particular the CCR3 
ligands; adhesion molecules, especially those mediated by 
P-selectin and α4 integrins; and IL-5. CCR3 expressed on 
eosinophils in humans and mice mediates both chemotaxis 
and adhesion to endothelial cells in vitro and in vivo. 
Although CCR3 deficiency does not affect the capacity of 
mice to generate peripheral blood eosinophilia in response 
to T. spiralis, eosinophils are not recruited to the jejunal 
mucosa, nor are they present in the striated muscle 
adjacent to encysted larvae [14]. P-selectin mediates 
IL-13-induced eosinophil transmigration but not eotaxin 
production in mice [15]; however, the regulatory role of 
P-selectin in eosinophil transmigration during T. spiralis 
infection is unclear. 
The trafficking of leukocytes to the gut-associated 
lymphoid tissue depends on the interaction of the α4β7 
integrin with its ligand, the mucosal vascular addressin 
cell-adhesion molecule-1 (MAdCAM-1) that is present on 
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the endothelium [16]. Both eosinophils and mast cells 
express α4β7 [17,18]. During T. spiralis infection, 
intestinal eosinophilia was delayed and reduced in 
β7-integrin-deficient mice but not in mice that were treated 
with moAb to integrin β7, whereas the suppression of 
mastocytosis was observed in both experimental models 
[19,20]. These facts indicate that the contribution of β7 
integrin to eosinophil tissue migration is inferior to that of 
the mast cells. Galectin-3 (Gal-3) has a crucial role in 
eosinophil recruitment and airway allergic inflammation of 
mice [21]. In humans, eosinophils from allergic donors 
express elevated levels of Gal-3, which co-localizes with α 
integrin and increase the rolling and firm adhesion of 
eosinophils on the VCAM-1 of endothelial cells [22]. 
Eotaxin is a fundamental regulator of physiological 
eosinophil trafficking during healthy states [23] and 
inflammation [24]. Ecalectin (galectin-9), which is 
produced by antigen-stimulated T cells, is a powerful 
eosinophil-specific chemoattractant in vitro and in vivo 
[25]. The role of these chemokines in eosinophilia that is 
caused by T. spiralis infection has been partially clarified. 
Eotaxin-1 (CCL11) is important in intestinal-tissue 
eosinophilia but not in peripheral eosinophilia during 
infection with T. spiralis [13]. In addition, eotaxin-2 
(CCL24) is only induced in the infected intestine. When 
CD4+OX22– T cells from rats infected with T. spiralis were 
transferred to uninfected rats and followed by a challenge 
infection, the cells that migrated into the intestinal 
epithelium induced intestinal eosinophilia [26]. There is a 
possibility that CD4+OX22– T cells produce more 
chemokines that have chemotactic activity against 
eosinophils than CD4+OX22+ T cells. 
In other helminthic diseases, such as that induced by 
Brugia malayi, alternatively activated macrophages (AAM) 
under the control of T-helper 2 (Th2)-dependent cytokines 
express unique products such as Arg 1 (arginase 1), FIZZ 1 
(resistin-like α) and YM1 (chitinase-like molecule), the 
functions of which have not been fully elucidated. 
Furthermore, AAM and/or YM1 are involved in eosinophil 
chemotaxis and might stimulate the migration of cells to 
parasites [27,28]. Induced AAM and YM1 have been shown 
in both mice and guinea pigs infected with T. spiralis 
[29,30]. 
Degranulation of eosinophils 
Eosinophils contain several types of granules and secretory 
organelles that are packed with major basic protein, 
eosinophil cationic protein, eosinophil-derived neurotoxin 
and eosinophil peroxidase. These proteins perform various 
biological activities [31]. It has been suggested that the 
immunoglobulins IgG and IgA (including secretory IgA) are 
able to trigger eosinophil degranulation [31]. However, the 
presence of IgE receptors on eosinophils remains 
controversial [31–33]. Recently, T cells have also been 
shown to have a role in eosinophil degranulation. Rag-1−/− 
mice that lacked T and B cells were infected with 
Nippostrongylus brasiliensis, and IL-4-expressing 
eosinophils were recruited to pulmonary tissues but failed 
to degranulate [34]. Reconstitution with CD4+ T cells 
promoted the accumulation of degranulated 
IL-4-expressing eosinophils, but only if the T cells were 
stimulated with a cognate antigen. These facts indicate 
that T-helper cells confer antigen specificity on eosinophil 
cytotoxicity but not on the cytokine responses. Whether a 
similar mechanism is invoked during the infection with T. 
spiralis has not been studied. 
Cytotoxic granules injure both the host tissue and the 
parasite. Eosinophils are thought to be involved in 
myocarditis in rats that are infected with T. spiralis [35]. 
Eosinophils are probably recruited by mediators, such as 
platelet-activating factor and eosinophil-chemotactic factor 
for anaphylaxis, that are released by degranulated mast 
cells that are activated by cognate antigen binding to IgE. 
Apoptosis of eosinophils 
Gon et al. [36] demonstrated that a considerable 
percentage of eosinophils in non-infected rats undergo 
apoptosis within a few hours, whereas the apoptosis rate of 
eosinophils from Trichinella-infected rats is notably lower. 
The inhibition of eosinophil apoptosis during the later 
stages of a Trichinella infection is related to the presence of 
IL-5. By contrast, the inhibition of eosinophil apoptosis 
during the earlier phases of the infection is thought to be 
unrelated to IL-5, possibly because of the presence of IL-3 
and the granulocyte-macrophage colony-stimulating factor 
(GM-CSF). At 2–5 weeks post-infection, when the recovery 
phase of a T. spiralis infection occurs, excess eosinophils 
disappear slowly from the jejunum of mice, whereas 
apoptotic eosinophils remain. The draining mesenteric 
lymph nodes also contain large numbers of apoptotic 
eosinophils [37]. Therefore, it is believed that jejunal 
eosinophils undergo apoptosis locally once the 
parasite-specific T cells cease to be prominent in the 
intestine and after the adult worms have been expelled. 
Protection by eosinophils in murine models 
It is evident that host defenses to T. spiralis are mediated 
through the action of CD4+ T-cell-derived cytokines 
[38–42]. Studies using IL-4 or IL-4-receptor-α deficient 
mice revealed that IL-4 has a crucial role in worm 
expulsion [43,44]. However, it is not clear whether IL-5 
and/or eosinophils can be implicated in the protective 
response of the host against the parasite. Neither IL-5 nor 
eosinophils were essential to control the parasite in either 
primary or challenge infections of CF1 mice using anti-IL-5 
moAb [8]. Furthermore, when non-immunized C3H/HeN 
and IL-5 transgenic (Tg) mice were compared to C3H/HeN 
and IL-5 Tg mice that were immunized with parasite 
somatic antigen, no differences were found in the recovery 
of ML or adult worms in the small intestine, the fecundity 
of female adult worms, or the infectivity of newborn larvae 
among the groups [45]. 
However, protective immune responses against the 
parasite should be analyzed carefully. Experimental 
models using CCR3-deficient BALB/c [14], CCL11- and 
IL-5-deficient BALB/c [13], and IL-5-deficient C57BL/6 
mice [46] show that eosinophils are not essential for the 
expulsion of adult worms after a primary infection. By 
contrast, IL-5 and/or eosinophils are involved in the 
expulsion of adult worms after a secondary infection in 
IL-5-deficient C57BL/6 mice [47]. Worm burdens in the 
skeletal muscle were increased and the frequency of 
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encysted larvae that exhibited necrosis was reduced in 
CCR3-deficient mice, compared with wild-type mice, 
during a primary infection [14]. This observation supports 
the hypothesis that eosinophils are cytotoxic versus the 
larval stage in mice [48,49]. Mouse eosinophils adhere to 
and kill T. spiralis newborn larvae in an 
antibody-dependent cellular cytotoxicity system [49] 
(Figure 2 and Figure 3). 
Untangling the role of eosinophils in experimental 
trichinellosis 
The discrepancy of the role of eosinophils in protection 
might be due to the mouse strains, the stages of the 
parasites and/or the experimental models used. Recently, 
strain-dependent resistance in the asthma model in mice 
has been reported to correlate with the apoptosis rate of 
lung-derived eosinophils [50]. Another possibility might be 
the difference in the degree of eosinophil activation. 
Hypodense eosinophils are commonly found in infected 
tissue, and cytotoxic activity against parasites is increased 
in this population of eosinophils [51,52]. Eosinophils can 
release large amounts of powerful mediators to kill 
parasites, injure tissues and remodel the damaged tissue. 
Thus, it is possible that eosinophils might be important in 
host defense. To validate this hypothesis, however, the 
interactions between each stage of the parasite and the 
eosinophils will require further study. In addition, a 
comparison of different Trichinella spp. might shed some 
light on host defense mechanisms [53–55]. For example, 
both adult worms and newborn larvae of Trichinella 
pseudospiralis exhibit stronger neutrophil chemotactic 
activity than those of T. spiralis [56]. 
Eosinophilia in humans 
Eosinophilia is present, with few exceptions, in most cases 
of human trichinellosis, inasmuch as it is the earliest and 
most important host response. Even in asymptomatic 
cases, increases in eosinophilia of up to 15% have been 
observed [2]. 
The mechanisms of eosinophil production in humans are 
similar to those described in experimental animals. 
Recently, a type-2 cytokine pattern of lymphocyte 
activation has been described during the muscular phase of 
infection in patients that are infected by either T. spiralis 
or Trichinella britovi [57]. Type-2 cytokines were elevated 
during the first nine months of infection. In particular, IL-5 
mRNA expression and protein production were both 
overproduced in peripheral blood mononuclear cells that 
were stimulated with T. spiralis or T. britovi antigens. The 
increased mRNA expression lasted at least one year; 
however, IL-5 protein levels peaked at two months and 
declined sharply after, even though considerable levels 
remained after 14 months [58]. 
Eosinophilia appears at an early stage of infection, 
before the development of general clinical signs and 
symptoms, and it increases between the second and fifth 
weeks of infection [59]. Eosinophilia might be low (<1000 
cells per μl), moderate (1000–3000 cells per μl) or high 
(>3000 cells per μl, and up to 19 000 cells per μl have been 
reported) [2]. Eosinophilia declines slowly and remains at 
low levels for several weeks, up to three months 
post-infection. The level of eosinophilia generally correlates 
with the degree of myalgia [60] and is significantly higher 
in people with neurological complications (i.e. 
neurotrichinosis). In fact, eosinophilia presenting with 
more than 4000 cells per μl was observed in 87.5% of 
patients with cerebral damage and in only 35.2% of those 
with no central neurological complications [61]. 
A significant correlation was observed between the 
presence of specific IgE in the patient sera during the first 
period of infection and blood eosinophilia levels. In fact, 
73% of patients with blood eosinophilia after four months of 
infection were positive for specific IgE compared to only 
28% of patients without eosinophilia [61]. During the acute 
stage of infection, a massive decrease of eosinophils in 
people with severe trichinellosis is a reasonable warning of 
a severe outcome, and a sudden decrease to 1% or less 
might even predict patient death [2]. The mechanism 
underlying this phenomenon is not known but is likely to 
be related to a massive peripheral migration. 
Human eosinophils could have a protective role because 
they are cytotoxic against newborn larvae in an 
antibody-dependent cellular cytotoxicity system [62]. 
Whether eosinophils are more cytotoxic than neutrophils is 
controversial. It is difficult to say whether the cytotoxic 
ability of these cells can have a meaningful role in 
protection against the parasite. The observation that 
eosinophil number decreases massively in severe infections 
[59] is in favor of a protective role in vivo as well. 
There is no doubt that the increase in activated 
eosinophil levels is responsible for damage to the vascular 
walls (probably because of the release of the major basic 
protein, which is elevated in patients with eosinophilia 
[63]), and this explains tissue damage in the central 
nervous system (CNS) [60] and other tissues. Figure 4 
shows a rich eosinophil infiltrate in the myocardial tissue 
of one patient who died because of severe trichinellosis. 
There is a correlation between eosinophil levels and muscle 
enzyme (creatine phosphokinase and lactate 
dehydrogenase) levels in skeletal muscles, and between 
eosinophil levels and myalgic score in patients infected by 
T. britovi; this indicates a relationship between eosinophil 
levels, and tissue damage and pain [59]. 
Concluding remarks 
Clinical observations indicate that allergic manifestations 
are typical of human trichinellosis. At the same time, 
eosinophils typically increase in number during infection. 
Is this phenomenon a side-effect of Th2 activation, or can 
these cells kill parasites in vivo and in vitro? The rapid 
decrease in eosinophil levels as a predictor of patient death 
is consistent with a protective role for eosinophils in 
humans. 
However, a chronic exposure to activated eosinophils 
might cause tissue damage in the muscle, myocardium and 
CNS, as exemplified in the most severe form of human 
trichinellosis, the so-called ‘neurotrichinosis’. Further 
studies are needed at a basic level to improve knowledge 
about mechanisms of eosinophil neurotoxicity. 
Despite the lack of controlled studies, corticosteroids are 
used by infectious-disease specialists to prevent 
immediate-type reactions during trichinellosis. 
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Corticosteroids should always be used in combination with 
anthelmintics to prevent an increased worm burden caused 
by delayed worm expulsion. Such anti-inflammatory drugs 
are also used to treat vasculitis, owing to its effects in 
inhibiting eosinophil activation and degranulation [31]. 
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Figure 1. Eosinophil induction, recruitment and products during Trichinella spiralis infection. Trichinella antigens stimulate dendritic cells and classic macrophages to 
interact with T cells. Activated T cells produce cytokines including GM-CSF, IL-3 and IL-5. In the bone marrow, precursors proliferate and differentiate into eosinophils. 
Eosinophil migration from the bone marrow to the vessels is controlled mainly by IL-5. Trichinella antigens might attract and affect eosinophils directly to interact 
with T cells. AAMs also attract eosinophils through Ym1 and/or Arg1. Strong chemoattractants for eosinophils are Gal-9, eotaxin-1 and eotaxin-2. Gal-3 functions as a 
cell-surface adhesion molecule to support eosinophil rolling and adhesion. Eosinophils around T. spiralis in the tissues produce cytokines, cytotoxic secretory 
products, growth factors, lipid mediators and neuro-mediators. These molecules might be involved in larval killing, tissue injury and/or tissue repair, together with 
various cells. The involvement of eosinophils in worm expulsion from the gut is still obscure. Abbreviations: AAM, alternatively activated macrophage; Arg1, arginase 
1; Eo, eosinophil; Gal-3, Galectin 3; Gal-9, Galectin 9; GM-CSF, granulocyte-macrophage colony-stimulating factor; IL-3, interleukin 3; IL-5, interleukin 5; YM1, 
chitinase-like molecule. 
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Figure 2. Electron micrograph of eosinophils adhering to Trichinella spiralis. Eosinophils from normal mice adhering to a Trichinella spiralis newborn larva incubated 
with immune sera. The arrows indicate intracellular vacuoles in contact with the cell basal membrane. Scale bar represents 1.3 μm. Reprinted, with permission, from 
Ref. [49]. 
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Figure 3. Electron micrograph of a degranulated eosinophil. Eosinophil (E) from a normal mouse, degranulated after adhesion to a Trichinella spiralis newborn larva 
(L) incubated with immune sera. ‘V’ indicates intracellular vacuoles with remnants of eosinophil granule content (arrows). Scale bar represents 1.25 μm. Reprinted, 
with permission, from Ref. [49]. 
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Figure 4. Eosinophils infiltrating the myocardial tissue of a trichinellosis patient. Eosinophils are indicated with arrows. This patient died of complications from 
trichinellosis. Tissue sample provided by Wanda Kociecka. Sample stained with May-Grunwald--Giemsa. Scale bar represents 50 μm. 
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Table 1. Molecules involved in eosinophil differentiation, trafficking, survival and activation during Trichinella infection 
Molecule Physiological role Role in Trichinella infection Refs 
IL-5 Differentiation and growth factor, eosinophil maturation and migration, 
the inhibition of eosinophil apoptosis 
Protectivea 
Protective in re-infection 
[8,45] 
[46] 
IL-3 Differentiation and growth factor, the inhibition of eosinophil apoptosis — [36] 
GM-CSF Differentiation and growth factor, the inhibition of eosinophil apoptosis — [36] 
CD80 Induction of eosinophilia — [12] 
CD86 Induction of eosinophilia — [12] 
CCR3 Eosinophil migration Protective to newborn larvae [14] 
β7 integrin Eosinophil migration — [19,20] 
Eotaxin-1 (CCL11) Eosinophil trafficking —b [13] 
Eotaxin-2 (CCL24) Eosinophil trafficking — [13] 
MBP Eosinophil degranulation product Protective to newborn larvae, and 
damaging to blood vessels and tissues 
[59,60,64] 
ECP Eosinophil degranulation product Protective to newborn larvae, and 
damaging to blood vessels and tissues 
[59,60,64] 
Ym1 AAM product, Th2 induction  [28] 
Arginase AAM product, Th2 induction  [29] 
aAvailable data are not conclusive. 
bDisruption of the CCL11 gene does not alter the expulsion. 
Abbreviations: AAM, alternatively activated macrophage; CCL, CC chemokines ligand; CCR, CC chemokine receptor; CD, cluster differentiation; ECP, eosinophil cationic 
protein; GM-CSF, granulocyte-macrophage colony-stimulating factor; IL, interleukin; MBP, major basic protein; Th, helper T cell; YM1, chitinase-like molecule. 
 
